@misc{oai:repo.qst.go.jp:00069411,
 author = {Arakawa, Ryosuke and Okumura, Masaki and Ito, Hiroshi and Seki, Chie and Takahashi, Hidehiko and Nakao, Ryuji and Suzuki, Kazutoshi and Okubo, Yoshiro and Suhara, Tetsuya and Halldin, Christer and 荒川 亮介 and 奥村 正紀 and 伊藤 浩 and 関 千江 and 高橋 英彦 and 中尾 隆士 and 鈴木 和年 and 大久保 善朗 and 須原 哲也 and ハルディン クリスタ},
 month = {Jul},
 note = {Norepinephrine transporters are of interest in pathophysiology of several psychiatric disorders, and norepinephrine reuptake inhibitors are used for the treatment of depression and attention deficit hyperactive disorder. (S,S)-[18F]FMeNER-D2 was recently developed as a radioligand for the measurement of norepinephrine transporter imaging with positron emission tomography (PET) [1]. In this study, norepinephrine transporter was visualized in human brain using this radioligand with PET and quantified by several quantification methods., NeuroReceptor Mapping　2008},
 title = {Quantitative analysis of norepinephrine transporter binding in human brain using PET with (S,S)-[18F]FMeNER-D2},
 year = {2008}
}